2,209
Views
44
CrossRef citations to date
0
Altmetric
Research Paper

Human liver epigenetic alterations in non-alcoholic steatohepatitis are related to insulin action

, , , , , , , & show all
Pages 287-295 | Received 02 Nov 2016, Accepted 06 Feb 2017, Published online: 30 Mar 2017

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (4)

Ioannis Konstantinidis, Pål Sætrom, Marine S. O. Brieuc, Kjetill S. Jakobsen, Hannes Liedtke, Caroline Pohlmann, Thomais Tsoulia & Jorge M. O. Fernandes. (2023) DNA hydroxymethylation differences underlie phenotypic divergence of somatic growth in Nile tilapia reared in common garden. Epigenetics 18:1.
Read now
Aurino M. Kemas, Sonia Youhanna & Volker M. Lauschke. (2022) Non-alcoholic fatty liver disease - opportunities for personalized treatment and drug development. Expert Review of Precision Medicine and Drug Development 7:1, pages 39-49.
Read now
Amy W Rachfal, Struan F A Grant & Stanley S Schwartz. (2021) The Diabetes Syndrome – A Collection of Conditions with Common, Interrelated Pathophysiologic Mechanisms. International Journal of General Medicine 14, pages 923-936.
Read now
D. A. Skuratovskaia, J. K. Sofronova, P. A. Zatolokin, K. Y. Popadin, M. A. Vasilenko, L. S. Litvinova & I. O. Mazunin. (2018) Additional evidence of the link between mtDNA copy number and the body mass index. Mitochondrial DNA Part A 29:8, pages 1240-1244.
Read now

Articles from other publishers (40)

Meysam Ramezani, Mahsa Zobeiry, Shahrokh Abdolahi, Behzad Hatami, Mohammad Reza Zali & Kaveh Baghaei. (2023) A crosstalk between epigenetic modulations and non-alcoholic fatty liver disease progression. Pathology - Research and Practice 251, pages 154809.
Crossref
Jie Chen, Fei Wu, Yehua Cao, Yuanxin Xing, Qingyong Liu & Zuohui Zhao. (2023) The novel role of LDHA/LDHB in the prognostic value and tumor-immune infiltration in clear cell renal cell carcinoma. PeerJ 11, pages e15749.
Crossref
Tina Rönn, Alexander Perfilyev, Josefine Jönsson, Karl-Fredrik Eriksson, Sine W Jørgensen, Charlotte Brøns, Linn Gillberg, Allan Vaag, Elisabet Stener-Victorin & Charlotte Ling. (2023) Circulating triglycerides are associated with human adipose tissue DNA methylation of genes linked to metabolic disease. Human Molecular Genetics 32:11, pages 1875-1887.
Crossref
Mohamed Zaiou. (2023) Peroxisome Proliferator-Activated Receptor-γ as a Target and Regulator of Epigenetic Mechanisms in Nonalcoholic Fatty Liver Disease. Cells 12:8, pages 1205.
Crossref
Ratika Sehgal, Alexander Perfilyev, Ville Männistö, Jyrki Ågren, Emma Nilsson, Pirjo Käkelä, Charlotte Ling, Vanessa D. de Mello & Jussi Pihlajamäki. (2023) Liver saturated fat content associates with hepatic DNA methylation in obese individuals. Clinical Epigenetics 15:1.
Crossref
Julia J. Wattacheril, Srilakshmi Raj, David A. Knowles & John M. Greally. (2023) Using epigenomics to understand cellular responses to environmental influences in diseases. PLOS Genetics 19:1, pages e1010567.
Crossref
Johanna K. DiStefano & Xiumei Wu. 2023. Epigenetics in Organ Specific Disorders. Epigenetics in Organ Specific Disorders 423 445 .
Dariusz Szukiewicz, Seweryn Trojanowski, Anna Kociszewska & Grzegorz Szewczyk. (2022) Modulation of the Inflammatory Response in Polycystic Ovary Syndrome (PCOS)—Searching for Epigenetic Factors. International Journal of Molecular Sciences 23:23, pages 14663.
Crossref
Simona Riccio, Rosa Melone, Caterina Vitulano, Pierfrancesco Guida, Ivan Maddaluno, Stefano Guarino, Pierluigi Marzuillo, Emanuele Miraglia del Giudice & Anna Di Sessa. (2022) Advances in pediatric non-alcoholic fatty liver disease: From genetics to lipidomics. World Journal of Clinical Pediatrics 11:3, pages 221-238.
Crossref
Nicholas D. Johnson, Xiumei Wu, Christopher D. Still, Xin Chu, Anthony T. Petrick, Glenn S. Gerhard, Karen N. Conneely & Johanna K. DiStefano. (2021) Differential DNA methylation and changing cell-type proportions as fibrotic stage progresses in NAFLD. Clinical Epigenetics 13:1.
Crossref
Charles I. V. Drummer, Fatma Saaoud, Yu Sun, Diana Atar, Keman Xu, Yifan Lu, Ying Shao, Candice Johnson, Lu Liu, Huimin Shen, Nirag C. Jhala, Xiaohua Jiang, Hong Wang & Xiaofeng Yang. (2021) Hyperlipidemia May Synergize with Hypomethylation in Establishing Trained Immunity and Promoting Inflammation in NASH and NAFLD. Journal of Immunology Research 2021, pages 1-35.
Crossref
Anat Yaskolka Meir, Maria Keller, Luise Müller, Stephan H. Bernhart, Gal Tsaban, Hila Zelicha, Ehud Rinott, Alon Kaplan, Yftach Gepner, Ilan Shelef, Dan Schwarzfuchs, Uta Ceglarek, Peter Stadler, Matthias Blüher, Michael Stumvoll, Peter Kovacs & Iris Shai. (2021) Effects of lifestyle interventions on epigenetic signatures of liver fat: Central randomized controlled trial. Liver International 41:9, pages 2101-2111.
Crossref
Marcello Dallio, Mario Romeo, Antonietta Gerarda Gravina, Mario Masarone, Tiziana Larussa, Ludovico Abenavoli, Marcello Persico, Carmelina Loguercio & Alessandro Federico. (2021) Nutrigenomics and Nutrigenetics in Metabolic- (Dysfunction) Associated Fatty Liver Disease: Novel Insights and Future Perspectives. Nutrients 13:5, pages 1679.
Crossref
Hannah Maude, Claudia Sanchez-Cabanillas & Inês Cebola. (2021) Epigenetics of Hepatic Insulin Resistance. Frontiers in Endocrinology 12.
Crossref
Xiaofang Zhang, Eralda Asllanaj, Masoud Amiri, Eliana Portilla‐Fernandez, Wichor M. Bramer, Jana Nano, Trudy Voortman, Qiuwei Pan & Mohsen Ghanbari. (2021) Deciphering the role of epigenetic modifications in fatty liver disease: A systematic review. European Journal of Clinical Investigation 51:5.
Crossref
Vanessa D. de Mello, Ratika Sehgal, Ville Männistö, Anton Klåvus, Emma Nilsson, Alexander Perfilyev, Dorota Kaminska, Zong Miao, Päivi Pajukanta, Charlotte Ling, Kati Hanhineva & Jussi Pihlajamäki. (2020) Serum aromatic and branched‐chain amino acids associated with NASH demonstrate divergent associations with serum lipids. Liver International 41:4, pages 754-763.
Crossref
Madelon L. Geurtsen, Vincent W. V. Jaddoe, Lucas A. Salas, Susana Santos & Janine F. Felix. (2019) Newborn and childhood differential DNA methylation and liver fat in school-age children. Clinical Epigenetics 12:1.
Crossref
Jeongeun Hyun & Youngmi Jung. (2020) DNA Methylation in Nonalcoholic Fatty Liver Disease. International Journal of Molecular Sciences 21:21, pages 8138.
Crossref
Shaza Asif, Nadya M. Morrow, Erin E. Mulvihill & Kyoung-Han Kim. (2020) Understanding Dietary Intervention-Mediated Epigenetic Modifications in Metabolic Diseases. Frontiers in Genetics 11.
Crossref
Nikolaos Perakakis, Konstantinos Stefanakis & Christos S. Mantzoros. (2020) The role of omics in the pathophysiology, diagnosis and treatment of non-alcoholic fatty liver disease. Metabolism 111, pages 154320.
Crossref
Ying Tian, Eri Arai, Satomi Makiuchi, Noboru Tsuda, Junko Kuramoto, Kentaro Ohara, Yoriko Takahashi, Nanako Ito, Hidenori Ojima, Nobuyoshi Hiraoka, Masahiro Gotoh, Teruhiko Yoshida & Yae Kanai. (2020) Aberrant DNA methylation results in altered gene expression in non-alcoholic steatohepatitis-related hepatocellular carcinomas. Journal of Cancer Research and Clinical Oncology 146:10, pages 2461-2477.
Crossref
Yng-Tay Chen, Wei-De Lin, Wen-Ling Liao, Ya-Ching Tsai, Jiunn-Wang Liao & Fuu-Jen Tsai. (2020) NT5C2 methylation regulatory interplay between DNMT1 and insulin receptor in type 2 diabetes. Scientific Reports 10:1.
Crossref
Fen Xu & Wanrong Guo. (2020) The progress of epigenetics in the development and progression of non-alcoholic fatty liver disease. Liver Research 4:3, pages 118-123.
Crossref
Ziqiang Zhu, Fang Cao & Xiaozhong Li. (2019) Epigenetic Programming and Fetal Metabolic Programming. Frontiers in Endocrinology 10.
Crossref
Matthew C. Sinton, David C. Hay & Amanda J. Drake. (2019) Metabolic control of gene transcription in non-alcoholic fatty liver disease: the role of the epigenome. Clinical Epigenetics 11:1.
Crossref
Paula Walle, Ville Männistö, Vanessa Derenji de Mello, Maija Vaittinen, Alexander Perfilyev, Kati Hanhineva, Charlotte Ling & Jussi Pihlajamäki. (2019) Liver DNA methylation of FADS2 associates with FADS2 genotypex. Clinical Epigenetics 11:1.
Crossref
Zaki A. Sherif. 2019. Nonalcoholic Fatty Liver Disease - An Update. Nonalcoholic Fatty Liver Disease - An Update.
Rita Rezzani, Caterina Franco & Luigi Fabrizio Rodella. (2019) Curcumin as a Therapeutic Strategy in Liver Diseases. Nutrients 11:10, pages 2498.
Crossref
Daniela Stols-Gonçalves, Luca Schiliró Tristão, Peter Henneman & Max Nieuwdorp. (2019) Epigenetic Markers and Microbiota/Metabolite-Induced Epigenetic Modifications in the Pathogenesis of Obesity, Metabolic Syndrome, Type 2 Diabetes, and Non-alcoholic Fatty Liver Disease. Current Diabetes Reports 19:6.
Crossref
Jiantao Ma, Jana Nano, Jingzhong Ding, Yinan Zheng, Rachel Hennein, Chunyu Liu, Elizabeth K. Speliotes, Tianxiao Huan, Ci Song, Michael M. Mendelson, Roby Joehanes, Michelle T. Long, Liming Liang, Jennifer A. Smith, Lindsay M. Reynolds, Mohsen Ghanbari, Taulant Muka, Joyce B.J. van Meurs, Louise J.M. Alferink, Oscar H. Franco, Abbas DehghanScott Ratliff, Wei Zhao, Lawrence Bielak, Sharon L.R. Kardia, Patricia A. Peyser, Hongyan Ning, Lisa B. VanWagner, Donald M. Lloyd-Jones, John Jeffrey Carr, Philip Greenland, Alice H. Lichtenstein, Frank B. Hu, Yongmei Liu, Lifang Hou, Sarwa Darwish Murad & Daniel Levy. (2019) A Peripheral Blood DNA Methylation Signature of Hepatic Fat Reveals a Potential Causal Pathway for Nonalcoholic Fatty Liver Disease. Diabetes 68:5, pages 1073-1083.
Crossref
Tetsutaro Yamaguchi, Kazuyoshi Hosomichi, Masahiro Takahashi, Shugo Haga, Takatoshi Nakawaki, Yu Hikita, Koutaro Maki & Atsushi Tajima. (2019) Orthognathic surgery induces genomewide changes longitudinally in DNA methylation in saliva. Oral Diseases 25:2, pages 508-514.
Crossref
Sonia García-Calzón, Alexander Perfilyev, Vanessa D de Mello, Jussi Pihlajamäki & Charlotte Ling. (2018) Sex Differences in the Methylome and Transcriptome of the Human Liver and Circulating HDL-Cholesterol Levels. The Journal of Clinical Endocrinology & Metabolism 103:12, pages 4395-4408.
Crossref
Glenn S. Gerhard, Ivana Malenica, Lorida Llaci, Xin Chu, Anthony T. Petrick, Christopher D. Still & Johanna K. DiStefano. (2018) Differentially methylated loci in NAFLD cirrhosis are associated with key signaling pathways. Clinical Epigenetics 10:1.
Crossref
Francisco Barajas-Olmos, Federico Centeno-Cruz, Carlos Zerrweck, Iván Imaz-Rosshandler, Angélica Martínez-Hernández, Emilio J. Cordova, Claudia Rangel-Escareño, Faustino Gálvez, Armando Castillo, Hernán Maydón, Francisco Campos, Diana Gabriela Maldonado-Pintado & Lorena Orozco. (2018) Altered DNA methylation in liver and adipose tissues derived from individuals with obesity and type 2 diabetes. BMC Medical Genetics 19:1.
Crossref
Cajsa Davegårdh, Sonia García-Calzón, Karl Bacos & Charlotte Ling. (2018) DNA methylation in the pathogenesis of type 2 diabetes in humans. Molecular Metabolism 14, pages 12-25.
Crossref
Maria Vasco, Rossella Paolillo, Concetta Schiano, Linda Sommese, Oreste Cuomo & Claudio Napoli. (2018) Compromised nutritional status in patients with end-stage liver disease: Role of gut microbiota. Hepatobiliary & Pancreatic Diseases International 17:4, pages 290-300.
Crossref
Mohammad Farzaei, Mahdi Zobeiri, Fatemeh Parvizi, Fardous El-Senduny, Ilias Marmouzi, Ericsson Coy-Barrera, Rozita Naseri, Seyed Nabavi, Roja Rahimi & Mohammad Abdollahi. (2018) Curcumin in Liver Diseases: A Systematic Review of the Cellular Mechanisms of Oxidative Stress and Clinical Perspective. Nutrients 10:7, pages 855.
Crossref
Zhiyong Cheng, Louise Zheng & Fabio A. Almeida. (2018) Epigenetic reprogramming in metabolic disorders: nutritional factors and beyond. The Journal of Nutritional Biochemistry 54, pages 1-10.
Crossref
Detlef Schuppan, Rambabu Surabattula & Xiao Yu Wang. (2018) Determinants of fibrosis progression and regression in NASH. Journal of Hepatology 68:2, pages 238-250.
Crossref
Manuel Suárez, Noemí Boqué, Josep del Bas, Jordi Mayneris-Perxachs, Lluís Arola & Antoni Caimari. (2017) Mediterranean Diet and Multi-Ingredient-Based Interventions for the Management of Non-Alcoholic Fatty Liver Disease. Nutrients 9:10, pages 1052.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.